Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.4, and our video podcast, CANCER BUZZ TV.
 

Keynote Speakers

Harlan Levine, MDOpening Keynote: Deconstructing the Value Equation

Harlan Levine, MD
President, Strategy and Business Ventures
City of Hope

Cancer care is a complex—and often controversial—topic, with multiple stakeholders that view “value” through many different lenses. Hear what value in cancer care means to patients and their caregivers and how this meaning is usually different for payers and employers. Then consider how we define value in oncology reflects on us as a society. Strategize how these different perspectives fit together to yield a value equation that takes into account outcomes, patient experience, cost, and time…and yet it is not enough. Each stakeholder brings their own perspective to the relative value of these variables, resulting in solutions that address some issues while creating new ones. Hear about the role you can play in defining oncology value going forward, and in so doing, help drive to a better—and more equitable—cancer care delivery system.

About Dr. Levine

Harlan Levine, M.D., is president of strategy and business ventures for City of Hope.  In this role, he is accountable for strategy, innovation and growth, drug commercialization, payer strategies and the Center for International Medicine. He also serves as the board chair of AccessHopeTM, City of Hope’s wholly owned subsidiary focused on serving the employer market and making leading-edge cancer care available to all regardless of geography.
 
Prior to City of Hope, Dr. Levine held executive roles at United Health Group, Towers Watson and Anthem Inc. He currently serves as a board member for Active Life Scientific, board member and Secretary of BioScienceLA and Keck Graduate Institute’s Board of Trustees. He is a strategic advisor to Quantum Health and a work group fellow for Health Evolution Forum’s New Models of Care Delivery.
 
He is certified by the American Board of Internal Medicine and licensed by the Medical Board of California. He earned his undergraduate degree from Harvard College, his medical degree from University of California San Francisco, and interned at Mount Zion Hospital and Medical Center in San Francisco. He completed his residency in internal medicine at Cedars-Sinai Health System in Los Angeles.


Learn more: @drharlanlevine

 

Debra Patt Headshot CircleLuncheon Keynote: Cancer Care’s Road to Recovery from the Global Pandemic

Debra Patt, MD, PhD, MBA, FASCO 
Executive Vice President, Public Policy and Strategic Initiatives
Texas Oncology

As healthcare systems navigated how to best keep patients with cancer safe during COVID-19, it resulted in dramatic drops in access to care, including preventative screenings, cancer management visits, and surgeries. Now that pandemic restrictions are lifting, the impact on disease progression, cancer morbidity, and death rates have yet to be realized. 

Learn strategies to increase awareness and ramp up screening efforts in your own community through programs like “Time to Screen,” a nationwide campaign that offers assistance and educational resources to connect patients with appropriate screenings and services.

About Dr. Patt

Debra Patt, MD, PhD, MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer research, serves on the US Oncology Research Breast Cancer Committee, and chairs the breast cancer subsection of the pathways task force for The US Oncology Network. Dr. Patt has expertise in healthcare policy and has testified before Congress to protect access to care for Medicare beneficiaries. She is a leader in clinical cancer informatics, and is involved in system innovations to enhance care delivery across a national network of oncology practices.

Dr. Patt is President of the Texas Society of Clinical Oncology, Secretary for the Community Oncology Alliance, and serves on the Council on Legislation or the Texas Medical Association. She is a nationally recognized leader in cancer research, has published many articles, and leads the service line for breast health services for the Dell Medical School.

Learn more: @dapattmd